New hope for hard-to-treat cancers: triple-drug combo targets HER2-positive tumors
Disease control
Recruiting now
This study tests a combination of three drugs (trastuzumab, serplulimab, and chemotherapy) in 20 adults with advanced bile duct or bladder cancers that have stopped responding to standard treatments. The goal is to see if this approach can shrink tumors and improve survival. Part…
Phase: PHASE2 • Sponsor: Xiujuan Qu • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC